Navigation Links
New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes
Date:5/25/2010

>"Medical advances made over the past several decades have revolutionized how we battle diabetes and its complications. Still, it takes a terrible toll," Johnson added. "This report illustrates the exciting work being pursued by our industry's dedicated researchers on behalf of patients and their families awaiting new treatments and renewed hope."

The report was released at a press conference featuring American TV icon Jerry Mathers, most famed for his role as "The Beaver."  Mathers, who suffers from diabetes, works to encourage prevention and calls on those who have the disease to seek proper treatment. Of the nearly 24 million Americans who have diabetes, an estimated six million don't know they have it. Another three million know but are not being treated and thus risk severe complications.

"As a patient who must cope every day with the effects of diabetes, I understand only too well the value of medicines and lifestyle changes," said Mathers, who is national spokesman for the Partnership for Prescription Assistance. Since the launch of PPA in 2005, more than 6.5 million uninsured and financially struggling Americans have found programs that can help them gain access to their medicines, including more than 60,000 in West Virginia.

The new medicines currently in the pipeline, some in early development stages and some awaiting FDA approval, include numerous drugs to treat eye diseases associated with diabetes. New medicines to treat foot ulcers could reduce the need for amputations. Researchers are pushing into new territories that include gene therapy and are working on such treatments as a once-weekly medication similar to a natural hormone critical to blood sugar regulation.

Johnson noted that diabetes not only causes great suffering, but also extracts a heavy economi
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
3. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
4. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
5. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
7. Weikang Bio-Technology Reports First Quarter 2010 Financial Results
8. Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry
9. Reportlinker Adds Global HIV Drugs industry
10. Shengtai Pharmaceutical, Inc. Reports Financial Results for the Third Quarter and the First Nine Months of Fiscal Year 2010
11. Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a leading ... announced today the appointments of Andrew ("Andy") Arno and ... of Directors. With these additions, the Asterias Board of ... independent. Andy Arno , 55, has ... He is currently Managing Director of Emerging Growth Equities, ...
(Date:8/20/2014)... , Aug. 20, 2014 The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down meth offenders and make arrests. ... Kansas blocked the sale ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: The Impact of ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... 3590) is complex legislation that affects virtually every ... provisions are beginning to take effect now. IVD ...
Breaking Medicine Technology:Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6
... Solutions, Inc. (Allscripts – NASDAQ: MDRX ) ... Paul M. Black, former Chief Operating Officer of Cerner ... Senior Vice President and Chief Legal Officer for the ... immediately.  Mr. Black will serve on the Board,s Compensation ...
... Hours, or even minutes, can mean the difference between life ... of Emergency Medical Services (EMS) Week from May ... about how quick recognition of stroke symptoms and timely response ... return to full health. Stroke is the ...
Cached Medicine Technology:Allscripts Adds Two Independent Directors to Board 2Allscripts Adds Two Independent Directors to Board 3Allscripts Adds Two Independent Directors to Board 4Allscripts Adds Two Independent Directors to Board 5"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 2"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 3"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 4"Emergency Medical Services Week" Highlights Stroke Survivors and Awareness 5
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, 2014 (HealthDay ... nearly 12 percent in the last decade, a new report ... teens using indoor tanning beds barely decreased. Both indoor tanning ... cancers, including deadly melanomas, the researchers noted. "Unfortunately, we ... reported wearing sunscreen, from 67.7 percent in 2001 to 56.1 ...
(Date:8/21/2014)... Orange, NJ. August 21, 2014. Researchers have published ... the outcomes of patients with motor complete spinal ... disparities in functioning at discharge and follow-up among ... ahead of print on August 2 by the ... (doi: 10.1016/j.apmr.2014.07.398). Findings included small but significant differences ...
(Date:8/21/2014)... 2014 CarePoint Health is proud ... Patel, MD, and Sujoy Menon, MD, have joined ... and Dr. Menon to the community. CarePoint Health’s ... imaging services to patients in Hudson County through ... Hospital and Hoboken University Medical Center. Our board ...
(Date:8/21/2014)... August 21, 2014 The Mount Sinai ... tool called RateMyHospital®, which captures real-time patient feedback and ... patient’s care. The tool, now available to admitted patients ... collects feedback regarding patient satisfaction using smartphones. , ... because it gives us the timely information we need ...
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... Cannabis Network that a company located in Massachusetts has ... the only marijuana patient verification system in ... welcome this new entity to our growing and compassionate ... our belief that these claims are inaccurate. , ...
Breaking Medicine News(10 mins):Health News:Fewer U.S. Teens Using Sunscreen, Study Finds 2Health News:Researchers examine impact of race and ethnicity in motor complete spinal cord injury 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 3Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2
... TOWNSHIP, Mich., Jan. 27 Financing has become a,very popular ... decade.,But long after you have had your "nip and tuck", ... looking for ways to get out of debt, and at ... surgery. , Dr. Charles Mok ...
... system chosen needs to match needs, culture of staff , , ... hospital is, the lower its rate of patient deaths and ... also saves centers money, the researchers report. , Although there ... Herrick, senior fellow at the National Center for Policy Analysis ...
... for the prevention of coronary heart disease, with ... at highest risk (ie, those with established heart ... estimation models may not be accurately achieved in ... groups whose 10-year "short-term" estimated risk seems low. ...
... Participants Control Weight Permanently , MIDLAND, Mich., Jan. 27 ... term is the challenge. With this Health Enhancement Systems ... NutriSum: Healthy Weight for Life ( ... to gain control of their weight -- and improve their ...
... Create SolutionsPITTSBURGH, Jan. 27 To ... and consultants, HM Insurance Group, a Highmark company, ... product line, which features dedicated worksite sales specialists, ... and membership management in a highly coordinated approach ...
... One in eight physicians have been inactive in the ... and most states do not require them to undergo competency ... , Because of the lack of regulation, patient safety could ... of Michigan Child Health Evaluation and Research (CHEAR) Unit and ...
Cached Medicine News:Health News:Lay Away Plan for Cosmetic Surgery 2Health News:'Wired' Hospitals Post Lower Death, Complication Rates 2Health News:'Wired' Hospitals Post Lower Death, Complication Rates 3Health News:Assessing the real risk of heart disease in young people with low short-term risks 2Health News:Thousands Look Better, Feel Better, and Have More Energy Because of NutriSum 2Health News:HM Insurance Group Launches Next Generation Worksite Product Line 2Health News:HM Insurance Group Launches Next Generation Worksite Product Line 3Health News:Most inactive physicians retain licenses, return to practice without competency review 2
The AMY method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of amylase activity in serum, plasma and urine....
The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
For the quantitative in vitro determination of Lipase in human serum and plasma....
Medicine Products: